Of note, WT1 has also been reported positive in more than 90% in adenomatoid tumors [50], 76% ovarian sex cord-stromal tumor [39], 77% serous papillary carcinoma of the ovary [40], and 29% of endometrioid carcinoma [40]. This evidence concerns the gene WT1 and ovarian sex cord-stromal tumor.